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Summary
At least every ten years, each specialty should reﬂect upon its past, its present and its future, in order to be able to reconﬁrm the direc-
tion in which it is headed, to adopt suggestions from inside and outside and, consequently, to improve. As such, the aim of this manu-
script is to provide the interested reader with an overview of how aortic surgery and (perhaps more accurately) aortic medicine has
evolved in Europe, and its present standing; also to provide a glimpse into the future, trying to disseminate the thoughts of a group of
people actively involved in the development of aortic medicine in Europe, namely the Vascular Domain of the European Association of
Cardio-Thoracic Surgery (EACTS).
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HISTORY
Where have we come from?
In order to understand where aortic surgery currently stands—
and how it is likely to progress—we have to appreciate its history.
As an integral part of cardiovascular surgery—itself an old, well-
deﬁned and well-developed specialty—aortic surgery in Europe
has a tradition spanning at least four decades. Initially limited to
a few developmental centres, surgery experienced a rapid ex-
pansion in the early 1990s when surgical techniques and perfu-
sion strategies were reﬁned and new diagnostic and treatment
modalities became available [1–3]. Scant data were available on
the natural course of aortic diseases and few people at that time
claimed true aortic surgery as their main ﬁeld of interest.
Furthermore, the aim was treating more than preventing as to
the avoidance of complications directly related to the surgical
approach. Due to the separation of cardiac and vascular surgery
in many centres, diverging interpretations and treatment strat-
egies of acute and chronic aortic diseases resulted. The
development of true aortic specialists was undoubtedly ham-
pered or delayed by this distinction.
CURRENT SITUATION
Where do we stand now?
In many centres, predominantly cardiac surgical units, a broad
interest in the physician–patient relationship in aortic diseases
has developed by establishing aortic outpatient clinics. This is
signiﬁcant as, for the ﬁrst time, the surgical centre, rather than
being a simple destination for surgical referrals, has now become
the monitor of disease progression and the need for interven-
tion. Therefore the treating surgeon, now acting as a diagnosing
physician, has a new role as patient manager, choosing adequate
diagnostics, advising the right time for treatment, as well as the
right modality, and maintaining surveillance of both the integrity
†Presented at the 2nd Strategic Meeting of the European Association for
Cardio-Thoracic Surgery, Windsor, UK, 10 February 2012.
‡Robert Bonser passed away before this article was published. The authors are
grateful for his valuable support for this and many other projects.
© The Author 2012. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
European Journal of Cardio-Thoracic Surgery 43 (2013) 226–230 REVIEW
doi:10.1093/ejcts/ezs413 Advance Access publication 12 November 2012
of the repair and the natural progression of as-yet-untreated
aortic segments. The result of this developmental process is a
surgeon-physician with a detailed knowledge of several contrib-
uting factors—the aortic specialist, in fact—unifying speciﬁc
knowledge which encompassed underlying disease processes,
natural course, pathophysiology, imaging, all treatment options
including open, endovascular and pharmacological treatment,
perfusion, hypothermia and organ protection, as well as the
knowledge of post-treatment surveillance.
THE FUTURE
Where are we heading?
Disease of the aorta is now being recognized as a distinct entity
with increasing incidence. It is acknowledged that the manage-
ment of both acute and chronic aortic conditions now has such
a broad evidence base that specialist knowledge, training and
skills are required to provide the best patient care. The special-
ism embraces all age groups: young patients are mostly affected
by connective tissue diseases (CTS); middle-aged patients are
affected by degeneration of bicuspid aortic valves, with or
without aneurysmal formation of the sinus of Valsalva or the
ascending aorta, caused by accompanying medial degeneration.
Elderly patients, in turn, may also develop the same phenotype
of disease (aortic valve and ascending aorta) but, due to other
underlying pathomechanisms, predominantly atherosclerosis and
calciﬁc degeneration.
All age groups may be afﬂicted by acute aortic dissection.
Valve-preserving strategies in acute and chronic situations are
highly likely to be implemented more widely. Furthermore, an
old disease has regained interest in the aging population, pene-
trating atherosclerotic ulcers (PAU), with its incidence rising expo-
nentially in the elderly [4]. Its discovery by chance, as well as
through enhanced alertness, has increased referrals. Furthermore,
better distinction of underlying disease mechanisms has improved
our knowledge (e.g. a 4.5-cm PAU is different to a 4.5-cm athero-
sclerotic aneurysm in terms of risk of rupture).
Based on the above-mentioned considerations, it is to be
expected that the known incidence of acute and chronic aortic
disease will increase [5]. Interestingly, in many aortic patients, the
underlying aortic disease is the only limiting problem substanti-
ating the likelihood that our treatment deﬁnitely improves sur-
vival. However, we must learn more if we are to provide true
beneﬁt to the patients under our care. Further trials and regis-
tries are necessary to reﬁne our decision-making and treatments
in conditions such as acute aortic dissection. The following are
some unanswered questions that need to be addressed:
• Acute aortic dissection type A: Can the speed of diagnosis
be improved? When and where should patients undergo
surgery? Should the false lumen be treated prophylactically
or followed in anticipation?
• Acute aortic dissection type B: In which patient groups
is urgent thoracic endovascular aortic repair (TEVAR) applic-
able? Could TEVAR for all be advantageous? Does
TEVAR-induced remodelling confer a prognostic effect? Do
bare-metal stent extensions confer an advantage?
• Chronic aortic dissections: Is the natural history truly known?
Are the current indications for intervention robust? Is the
frozen elephant trunk providing prognosis or paralysis?
• Chronic aneurysmal disease: Do our size criteria for inter-
vention need to be validated? Is off-label TEVAR use really
working? When should saccular aneurysms be treated?
• Acute aortic syndromes: Have we entirely understood the
natural history of intramural haematoma and penetrating
atherosclerotic ulcers and the need for intervention?
• Organ protection: Can we safely move to warmer tempera-
tures during hypothermic circulatory arrest? Are our brain and
spinal cord protection strategies adequate? Can we augment
the ‘safety net’ by adding pharmacological adjuncts?
Several other important and interesting questions in the diag-
nostics and treatment of acute and chronic proximal thoracic
aortic pathology have to be addressed in the near future, such
as the degree of atherosclerotic involvement of the ascending
aorta as a predictor for cardiac as well as non-cardiac ischaemic
events after coronary artery bypass grafting (CABG) [6].
The surgical community is increasingly challenged to advise
for or against treatment in elderly patients and we should
realize that, in the same way that a paediatric patient should
not be seen as a small adult, the elderly should not be seen as
advanced adults [7].
A closer look at the composition of the aortic wall, its mech-
anical behaviour, its elastic properties and their impact on dila-
tion, dissection and rupture in bicuspid aortic valve disease will
help to prevent unforeseen acute events in the future [8].
A precise experimental and subsequent clinical evaluation of
warmer systemic circulatory arrest times is further warranted, as
well as the signiﬁcance of pressure and perfusion of the brain in
relation to systemic and perfusate temperatures [9]. The addition-
al consideration of lower body perfusion in aortic arch surgery,
either ante- or retrograde, and its implication in preventing
clinical and subclinical organ injury, presents a broad ﬁeld of
research [10].
TREATMENT OPTIONS OF AORTIC PATHOLOGIES
Endovascular stenting has broadened the scope of aortic thera-
peutics and has led to the development of many alternative
treatment approaches using isolated stenting and hybrid stent-
surgery techniques. Some of these have become routine and
may be judged as validated and standardized [11–13]. However,
better understanding of the limitations of endovascular therapy,
as well as acknowledgement of the excellent results for conven-
tional aortic surgery, must be considered before extending
endovascular options to all aortic pathologies and new patient
populations [14]. A multidisciplinary approach may clearly serve
to chose the adequate treatment modality in the individual
setting as induced complications might not be handled in an ad-
equate fashion by non-cardiac surgeons (e.g. endovascular treat-
ment of ascending aortic pathology).
AORTIC CENTRES
The logical consequence of the evolution of aortic surgery is the
creation of aortic centres, capable of treating the entire organ
with all available diagnostic and therapeutic options. The leaders
of such centres are likely to be cardiovascular surgeons with ex-
perience in both cardiac and vascular surgical disciplines, includ-
ing endovascular skills. All treatment options should be available
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for the individual patient, with choice of treatment being
decided consensually at multidisciplinary team (MDT) meetings.
These MDT meetings should be populated by open and endo-
vascular surgeons, cardiologists, cardiovascular physicians, inter-
ventional and diagnostic radiologists, and neurophysiologists.
Additional expertise including anaesthesiology, rheumatology
and microbiology will be essential when evaluating treatment
options. The referral pattern of an aortic centre must be
similar to the referral pattern for percutaneous coronary inter-
ventions, with 24 hours a day, 7 days a week, year-round avail-
ability. Regarding referral patterns, cardiovascular surgeons
can have their own recruitment of aortic lesions if they screen
more systematically the cardiovascular population they are
already taking care of.
YOUNG ACADEMICS
How to attract younger colleagues?
Aortic surgery and the management of the aortic patient are
intellectually and technically challenging and it is important
that the current specialty fosters high-calibre candidates to be
the leaders of the future. In an era in which aspects of our spe-
cialty are unpopular with younger doctors in training, in order
to get the highest calibre candidates, we have to attract them.
Halsted’s master–apprentice model is no longer applicable in
today’s educational system. Young physicians need a career
model as well as achievement-based rewards, otherwise they
will reorientate themselves. We have to do our best to amelior-
ate the framework conditions for trainees. The management of
patients with aortic disease is a fascinating medical challenge
that should attract the best in our ﬁelds, as long as we take
the time to mentor bright individuals who show interest in the
area.
REQUIRED SKILLS
A short summary of the diagnostic skills required
of the aortic specialist
As the ultimate and main responsibility rests with the surgeon, it
is imperative that the aortic specialist has a broad knowledge in
imaging. Consequently, interpretation of echocardiography,
computed tomography angiography (CTA) and functional mag-
netic resonance imaging (MRI) is essential [15]. Intravascular
ultrasound (IVUS) may serve as an adjunct, not only because of
its potential for intraoperative measurements but, even more sig-
niﬁcantly, because it provides the surgeon with his own
decision-making tool.
Surgical and endovascular skills
Young surgeons must have the chance to develop and mature
through a broad surgical training program, with a clear and
deﬁned aim in a deﬁned time period, designed to provide a
solid grounding in surgery, endovascular therapy and science.
For future generations it will be imperative to restructure educa-
tion in cardiac and vascular surgery in respect of the minor
subjects, such as endovascular training versus trauma surgery
and legal medicine.
Perfusional and anaesthesiological knowledge
Any kind of open, endo or hybrid thoracic aortic repair must
provide a ‘safety net’ of optional cardiopulmonary bypass (CPB)
and hypothermic circulatory arrest, in case of unforeseen com-
plications such as retrograde type A aortic dissection. As a con-
sequence, the availability of CPB and the knowledge of
adjunctive organ protection techniques, such as antegrade se-
lective cerebral perfusion and cerebrospinal ﬂuid drainage, are
an indispensable part of these operations. Performing such pro-
cedures without these facilities should be abandoned.
TIMEPOINT OF SPECIALIZATION
When and how to specialize in aortic medicine?
It is imperative that the aortic specialist of the future has a broad
training in both cardiac and vascular surgery. Interest in the spe-
cialty should arise early but a deﬁnitive focus on aortic medicine
with, for example, a 50% aortic case-load of his or her specialism
should be the zenith after one-and-a-half decades of cardiovas-
cular surgery. It has to be the task of the academic surgical com-
munity to decide whether a certiﬁcation for an aortic specialist
might improve the quality of the specialty. After all, it is clear
that treatment of the aorta does also include treatment of its
branches and demands a broad theoretical and practical knowl-
edge of disease processes in the entire vascular system.
RELATIONSHIP TO INDUSTRY
Without support and partnership of the medical industry, a
highly emergent and implant-dependent specialty like aortic
medicine is not possible. However, future developments have to
be made according to a common sense of need and request of
the closely collaborating physician and engineer: otherwise tech-
nology seeks indication and not vice versa. Improved coordin-
ation and interaction between physicians and industry could
solve many issues.
ROLE OF THE VASCULAR DOMAIN OF EACTS
Aim of the Vascular Domain
The restructuring of EACTS into domains initiated a boost in the
focusing of knowledge and helped substantially in driving pro-
jects and ameliorating the quality of congresses and courses. By
creating the opportunity to work in smaller groups of dedicated
specialists, ﬂexibility and target orientation were substantially
promoted and the results can already be seen. So the aim of fa-
cilitating meetings with highly skilled and motivated people, in
order to enhance professional, scientiﬁc and educational prod-
uctivity was achieved in a short period of time.
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Professional productivity
By adding ‘professional challenges’ sessions to the programme of
the annual EACTS meeting, we were able to distribute broad
knowledge regarding the current state of the art, not only of
surgical but—equally importantly—perfusional, monitoring and
pharmacologic aspects of treating acute type A and type B aortic
dissection. This approach of selecting speciﬁc topics and going
into detail, with the additional aid of intraoperative videos, has
turned out to be a major success and will be continued in the
future. Furthermore the open attitude of the group towards provi-
sion of support in individual cases has encouraged physicians to
ask for professional exchanges resulting in mutual beneﬁt.
Scientiﬁc productivity
Current achievements. The Vascular Domain was founded in
2008 and objectives for its term of ofﬁce were quickly
established. The domain decided to found a European Registry
for Aortic Disease (EuRADa), which is already functional, working
and growing (http://eurada.pro). Additionally, several hot topics
in the aortic ﬁeld were addressed and review articles and
position papers were published, as well as original articles. One
of the greatest achievements of the group was the common
ESC-EACTS position paper on the current use of thoracic
endovascular aortic repair (TEVAR), a benchmark paper on the
evidence—or lack thereof—in treating acute Type A aortic
dissection, as well as a literature review a on the importance of
preserving the left subclavian artery as a collateral vessel to the
spinal cord during TEVAR [16–18].
Future projects. There are several projects under way, which
address important, unsolved questions such as the
implementation of new biomarkers in the diagnosis of acute and
chronic thoracic aortic pathology, as well as a randomized trial
of adding a frozen elephant trunk prosthesis to a hemi-arch
replacement in acute Type A aortic dissection. Furthermore, a
state-of-the-art paper on spinal cord perfusion and the
prevention of spinal cord injury during open and endovascular
treatment is under way, as well as a position paper addressing
the current status on thoraco-abdominal hybrids and total
endovascular approaches. Finally, in late 2012, results of a
multi-centre registry on conventional aortic arch replacement
will be shared with the scientiﬁc community.
Educational productivity
The EACTS Vascular course in Windsor, being held on an annual
basis at the end of March, enjoys growing popularity by estab-
lishing a programme tailored to current needs, not only for phy-
sicians in training but equally for experienced physicians who
want to catch up with the latest trends and technologies in
aortic medicine. Recently, simulators have been added to the
programme and will help to make physicians familiar with endo-
vascular techniques and their current applications. Furthermore,
during the annual meeting, education in imaging will be added
so that the surgeon will also make a step forward in being inde-
pendent with regard to image guidance and quality control.
Global activities of the Vascular Domain
By creating the position of a liaison ofﬁcer to the United States,
the EACTS council has enabled an important step in strengthening
scientiﬁc relations to North America. This position’s role is to
promote mutual exchange during annual meetings by integrat-
ing one another and also by enhancing intercontinental scientiﬁc
collaboration on the aortic sector. Early results have already
been achieved.
Domain forecast for the years to come
It is our aim to continue to function as a source of competence in
all questions regarding aortic disease and its treatment, not only in
theory but as active specialists. We aim to expand our aortic data-
base (EuRADa) to become the benchmark of knowledge regarding
each and every detail of aortic medicine. A focus, not only on
patients treated but also on patients under surveillance before
treatment, will provide a better understanding of the natural
course of aortic diseases, as well as the impact of pharmacological
intervention (connective tissue disease, bicuspid aortic valves). We
do want to attract young physicians to make a career decision in
favour of cardiovascular surgery with an aortic focus, and to
support them during their development into aortic specialists.
Through the mutual efforts of past and active members of the
Domain, as well as with the support of every EACTS member
willing to contribute, the Vascular Domain will expand its
leading role in differentiated discussion, analysing problems,
answering open questions and advancing the ﬁeld of aortic
medicine for the sake of our patients, as well as for our own de-
velopment in order to better understand the disease and
improve its treatment.
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Obituary
On 29th October 2012 a great surgeon and academic teacher passed away. Robert Stuart Bonser was known to the medical community
not only in the United Kingdom and Europe but also around the world, not merely because of his outstanding skills as a surgeon but
mostly due to his altruistic sense of teaching and academic leadership. We, as members of the Vascular Domain of EACTS, were able to
welcome Robert to the group in 2008. From the outset it was clear that Robert's contributions enhanced our efforts in many ways. We
remember fondly a highly stimulating programme committee in Windsor. Robert produced a remarkable and scientiﬁcally enriching
programme for the annual meeting. His efforts for EACTS culminated in a brilliant review addressing evidence, lack of evidence, contro-
versy and debate in the provision and performance of the surgery of acute type A aortic dissection. This is but one of the many ﬁelds
in which he was an expert. Throughout his ﬁnal illness, he kept in touch with us and continually hoped to resume the work that he so
much valued, enjoyed and excelled at.
It is clear that Robert will be missed, especially by those who had an interest in aortic surgery in the UK, where he was the surgeon
of last resort. Many of his colleagues recall stories of Bob coming to the rescue and sorting out a difﬁcult case or situation. We are
grateful that we had the privilege of knowing him and learning from him. Robert represented the ideal of an altruistic teacher and a
thoughtful and supportive academic leader. This memory will be cherished by all who knew him.
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